SFX by Ex Libris Inc.

Title:	Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size
Source:	Science [0036-8075] Heallen, T yr:2011

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Morrisey, E. "Not Too Large and Not Too Small-Just the Right Size: A Hippo-Sized Heart." Circulation research 109.6 (2011): 614-615.
description	2.	Bostrm, P. "C/EBPβ controls exercise-induced cardiac growth and protects against pathological cardiac remodeling." Cell 143.7 (2010): 1072-1083.
description	3.	Pan, D. "The hippo signaling pathway in development and cancer." Developmental cell 19.4 (2010): 491-505.
description	4.	Khalili, M. "Illustration of the heart and blood vessels in medieval times." International journal of cardiology 143.1 (2010): 4-7.
description	5.	Varelas, X. "The Hippo pathway regulates Wnt/beta-catenin signaling." Developmental cell 18.4 (2010): 579-591.
description	6.	Zhao, Karen n. "The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal." Nature Cell Biology 13.8 (2011): 877-883.
description	7.	Varelas, X. "TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal." Nature cell biology 10.7 (2008): 837-48.
description	8.	Zhao, B. "The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version." Genes & development 24.9 (2010): 862-874.
description	9.	McMullen, Julie R R. "DIFFERENCES BETWEEN PATHOLOGICAL AND PHYSIOLOGICAL CARDIAC HYPERTROPHY: NOVEL THERAPEUTIC STRATEGIES TO TREAT HEART FAILURE." Clinical and experimental pharmacology & physiology 34.4 (2007): 255-262.
description	10.	Bernardo, Bianca C. "Molecular distinction between physiological and pathological cardiac hypertrophy: Experimental findings and therapeutic strategies." Pharmacology & therapeutics 128.1 (2010): 191-227.
description	11.	Varelas, X. "The Crumbs Complex Couples Cell Density Sensing to Hippo-Dependent Control of the TGF-β-SMAD Pathway." Developmental cell 19.6 (2010): 831-844.
description	12.	Nishida, E. "A molecular mechanism that links Hippo signalling to the inhibition of Wnt/β-catenin signalling." EMBO journal 31.5 (2012): 1109-1122.
description	13.	Paramasivam, M. "Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor." Molecular biology of the cell 22.19 (2011): 3725-33.
description	14.	Flores, Elsa R. "Stem Cell Proliferation in the Skin: {alpha}-Catenin Takes Over the Hippo Pathway." Science signaling 4.183 (2011).
description	15.	Sassoli, C. "Mesenchymal stromal cells affect cardiomyocyte growth through juxtacrine Notch-1/Jagged1 signaling and paracrine mechanisms: Clues for cardiac regeneration." Journal of molecular and cellular cardiology 51.3 (2011): 399-408.
description	16.	Lim, D. "The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis." Proceedings of the National Academy of Sciences of the United States of America 107.18 (2010): 8248-8253.
description	17.	Parsons, Linda M. "Lgl/aPKC and Crb regulate the salvador/warts/hippo pathway." Fly 4.4 (2010): 288-93.
description	18.	Gupta, J. "The transcriptional coactivator PGC-1alpha mediates exercise-induced angiogenesis in skeletal muscle." Proceedings of the National Academy of Sciences of the United States of America 106.50 (2009): 21401-21406.
description	19.	Radu M, M. "The DeMSTification of mammalian Ste20 kinases." Current biology 19.10 (2009): -5.
description	20.	Lin HH, Chen YH, Chang PF, Lee YT, Yet SF, Chau LY, Lee-Young Y. "Heme oxygenase-1 promotes neovascularization in ischemic heart by coinduction of VEGF and SDF-1." Journal of Molecular and Cellular Cardiology 45.1: 44-55.